IMMUNIC appoints Erik Lundgren as Chief Executive Officer
IMMUNIC, INC. has entered into an employment agreement with Erik Lundgren to serve as CEO effective May 22, 2026. The appointment represents a leadership change for the biopharmaceutical company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day